Enterai Bioavailability of Human Granulocyte Colony Stimulating Factor Conjugated with Poly(ethylene glycol)

Pharmaceutical Research

Volumn 13, Issue 1, 1996, Pages 102-107

  Jensen Pippo, Kathleen E ^a   Whitcomb, K Lane ^a   DePrince, Randolph B ^b   Ralph, Lloyd ^a   Habberfield, Alan D ^a  

^a AMGEN INC   (United States)

^b GLAXOSMITHKLINE   (United States)

Author keywords

Enterai; Intraduodenal; Pegylation; Recombinant human granulocyte colony stimulating factor

Indexed keywords

CHYMOTRYPSIN; MACROGOL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOAVAILABILITY; BONE MARROW CELL; DRUG ACTIVITY; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG HYDROLYSIS; DRUG SYNTHESIS; DRUG UPTAKE; FEMALE; HAMSTER; INTESTINE ABSORPTION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTEMIC CIRCULATION;

ANIMALS; BIOLOGICAL AVAILABILITY; DUODENUM; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; HYDROLYSIS; INFUSIONS, PARENTERAL; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; THERAPEUTIC EQUIVALENCY;

EID: 0029928302     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016089503186     Document Type: Article

References (14)

1. P. L. Smith, D. A. Wall, C. H. Gochoco and G. Wilson. Routes of delivery: Case studies. (5) Oral absorption of peptides and proteins. Adv. Drug Del. Rev. 8:253-290 (1992).
2. S. Muranashi. Absorption enhancers. Crit. Rev. Ther. Drug Carrier Systems. 7:1-33 (1990).
3. C. Delgado, G. E. Francis and D. Fisher. The uses and properties of PEG-linked proteins. Crit. Rev. in Ther. Drug Carrier Systems. 9:249-304 (1992).
4. M. L. Nucci, R. Shorr and A. Abuchowski. The therapeutic value of poly(ethylene glycol)-modified proteins. Adv. Drug Del. Rev. 6:133 (1991).
5. E. Sada, S. Katoh, K. Yamanaka and Y. Itakura. Resistance to proteolysis of antibody ligands modified with polyethylene glycol. J. Fermentation and Bioengineering. 71:137-139 (1991).
6. H. Tanaka, R. Satake-Ishikawa, M. Ishikawa, S. Matsuki and K. Asano. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats. Cancer Res. 51:3710-3714 (1991).
7. G. Morstyn and A. W. Burgess. Hemopoietic growth factors: A review. Cancer Res. 48:5624-5637 (1988).
8. S. C. Porter. Coating of Pharmaceutical Dosage Forms. In Remington's Pharmaceutical Sciences. Mack Publishing Company, Easton, PA (1985).
9. Y. Ushirogawa, Y. Nakahigashi, A. Kiriyama and K. Takada. Effect of organic acids, trypsin inhibitors and dietary protein on the pharmacological activity of recombinant human granulocyte colony-stimulating factor (rhG-CSF) in rats. Int. J. Pharm. 81:133-141 (1992).
10. T. Y. Ma, D. Hollander, P. Krugliak and K. Katz. PEG 400, a hydrophilic molecular probe for measuring intestinal permeability. Gastroenterlogy 98:39-46 (1990).
11. D. Hollander, S. Koyama, V. Dadufalza, D. Q. Tran, P. Krugliak, T. Ma and K. Y. Ling. Polyethylene glycol 900 permeability of rat intestinal and colonie segments in vivo and brush border membrane vesicles in vitro. J. Lab. Clin. Med. 113:505-515 (1989).
12. J. R. Pappenheimer and K. Z. Reiss. Contribution of solvent drag through intercellular junctions to absorption of nutrients by the small intestine of the rat. J. Membr. Biol. 100:123-136 (1987).
13. H. Tanaka and T. Tokiwa. Influence of renal and hepatic failure on the pharmacokinetics of recombinant human granulocyte colony-stimulating factor (KRBN8601) in the rat. Cancer Res. 50:6615-6619 (1990).
14. R. Satake-Ishikawa, M. Ishikawa, Y. Okada, M. Kakatini, M. Kawagishi, S. Matsuki and K. Asano. Chemical modification of recombinant human granulocyte colony-stimulating factor by polyethylene glycol increases its biological activity in vivo. Cell Structure Function. 17:157-160 (1992).